業績集

  1. ホーム
  2. 業績集

業績一覧

2023年

英文論文

  1. Kono E, Isozumi U, Nomura S, Okoshi K, Yamamoto H, Miyata H, Yasufuku I, Maeda H, Sakamoto J, Uchiyama K, Kakeji Y, Yoshida K, Kitagawa Y. Surgical Experience Disparity Between Male and Female Surgeons in Japan. JAMASurgery 157(9):e222938, 2022
  2. Okoshi K, Endo H, Nomura S, Kono E, Fujita Y,Yasufuku I, Hida K, Yamamoto H, Miyata H, Yoshida K, Kakeji Y, Kitagawa Y. "Comparison of short term surgical outcomes of male and female gastrointestinal surgeons in Japan: retrospective cohort study. BMJ 378:e070568, 2022"
  3. Sakai SA, Aoshima M, Sawada K, Horasawa S, Yoshikawa A, Fujisawa T, Kadowaki S, Denda T, Matsuhashi N, Yasui H, Goto M, Yamazaki K, Komatsu Y, Nakanishi R, Nakamura Y, Bando H, Hamaya Y, Kageyama SI, Yoshino T, Tsuchihara K, Yamashita R. Fecal microbiota in patients with a stoma decreases anaerobic bacteria and alters taxonomic and functional diversities. Frontiers in cellular and infection microbiology 12:925444, 2022
  4. Ozaki Y, Tsurutani J, Mukohara T, Iwasa T, Takahashi M, Tanabe Y, Kawabata H, Masuda N, Futamura M, Minami H, Matsumoto K, Yoshimura K, Kitano S, Tanano T. Data of programmed death-ligand 1 expression and VEGF: Nivolumab, bevacizumab and paclitaxel For HER2-negative metastatic breast cancer. Data in Brief 45:108558, 2022
  5. Takahashi T, Ishida K, Emi Y, Sakamoto M, Imura J, Aishima S, Muro K, Uetake H, Oki E, Katayose Y, Yoshida K, Unno M, Hyodo I, Tomita N, Sugihara K, Maehara Y. Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial. Cancers 14(18):4392, 2022
  6. Tanaka H, Imai H, Matsuhashi N, Higashi T, Kiyama S, Okumura N, Murase K, Takahashi T, Saigo C, Takeuchi T, Yoshida K. The Prognostic Significance of a Histological Response to Preoperative Chemotherapy in Patients With Synchronous Colorectal Liver Metastases. International Surgery 106(1): 5-17, 2022
  7. Oshi M, Tokumaru Y, Benesch MG, Sugito N, Wu R, Yan L, Yamada A, Chishima T, Ishikawa T, Endo I, Takabe K. High miR-99b expression is associated with cell proliferation and worse patient outcomes in breast cancer. American Journal of Cancer Research 12(10):4840-4852, 2022
  8. Wu R, Yu I, Tokumaru Y, Asaoka M, Oshi M, Yan L, Okuda S, Ishikawa T, Takabe K. Elevated bile acid metabolism and microbiome are associated with suppressed cell proliferation and better survival in breast cancer. American Journal of Cancer Research 12(11):5271-5285, 2022
  9. Sato Y, Tanaka Y, Imai T, Okumura N, Matsuhashi N, Takahashi T, Shimokawa T, Yoshida K. Serum diamine oxidase activity derived from response to chemotherapy affects adverse events and serum amino acid levels. Supportive Care in Cancer 30(11):9369-9377, 2022
  10. Niwa A, Taniguchi T, Tomita H, Okada H, Kinoshita T, Mizutani C, Matsuo M, Imaizumi Y, Kuroda T, Ichihashi K, Sugiyama T, Kanayama T, Yamaguchi Y, Sugie S, Matsuhashi N, Hara A. Conditional ablation of heparan sulfate expression in stromal fibroblasts promotes tumor growth in vivo. PLoS One 18(2):e0281820, 2023
  11. Hayashi H, Tajima JY, Yokoi R, Sato Y, Kiyama S, Takahashi T, Okumura N, Tanaka Y, Ibuka T, Kumada K, Shimizu M, Matsuhashi N. Patient with suspected severe acute respiratory syndrome coronavirus 2 infection with successful emergency surgery for ulcerative colitis-associated toxic megacolon. Surgical Case Reports 9(1):32, 2023
  12. Matsuoka S, Fujii H, Iihara H, Ohata K, Hirose C, Watanabe D, Sadaka S, Kiyama S, Makiyama A, Takahashi T, Kobayashi R, Matsuhashi N, Suzuki A. Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy. Anticancer Research 43:2351-2357, 2023
  13. Futamura M, Ishihara K, Nagao Y, Ogiso A, Niwa Y, Nakada T, Kawaguchi Y, Ikawa A, Kumazawa I, Mori R, Kitazawa M, Hosono Y, Kuno M, Kawajiri M, Nakakami A, Takeuchi M, Morikawa A, Tokumaru Y, katagiri Y, Asano Y, Mushika Y, shimokawa T, Matsuhashi N. Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicanter phase Ⅱ Clinical trial (PerSeUS-BC04). Breast Cancer 30(2):293-301, 2023
  14. Umemoto K, Sunakawa Y, Ueno M, Furukawa M, Mizuno N, Sudo K, Kawamoto Y, Kajiwara T, Ohtsubo K, Okano N, Matsuhashi N, Itoh S, Matsumoto T, Shimizu S, Otsuru T, Hasegawa H, Okuyama H, Ohama H, Moriwaki T, Ohta T, Odegaard JI, Nakamura Y, Bando H, Yoshino T, Ikeda M, Morizane C. Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer. British Journal of Cancer 128(8):1603-1608, 2023
  15. Asai R, Tanaka Y, Sato Y, Fujibayashi S, Endo M, Matsuhashi N. Esophageal epiphrenic diverticulum treated with laparoscopic surgery in a patient with systemic sclerosis: A rare case report. International Journal of Surgery Case Reports 106(2023)108136, 2023
  16. Fukada M, Murase K, Higashi T, Yasufuku I, Sato Y, Tajima JY, Kiyama S, Tanaka Y, Okumura N, Takahashi T, Matsuhashi N. Drain fluid and serum amylase concentration ratio is the most reliable indicator for predicting postoperative pancreatic fistula after distal pancreatectomy. BMC Surgery 23:87, 2023
  17. Imoto S, Wang K, Bi Xi-wen, Liu G, Im Young-Hyuck, Im Seock-Ah, Sim Sung Hoon, Ueno T, Futamura M, Toi M, Fujiwara Y, Ahn Sung Gwe, Lee Jeong Eon, Park Yeon Hee, Takao S, Oba Mari Saito, Kitagawa Y, Nishiyama M. Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO‑BC1). Breast Cancer 30(3):412-423, 2023
  18. Hayashi H, Yasufuku I, Higashi T, Chikaishi W, Yokoi R, Fukada M, Sato Y, Asai R, Tajima JY, Saigo C, Makiyama A, Tanaka Y, Okumura N, Murase K, Takahashi T, Futamura M, Takeuchi T, Matsuhashi N. Late recurrent gastric carcinoma 12 years after surgery with attenuation of CD44 variant 9 expression. Surgical Case Reports 9(1):87, 2023
  19. Sato Y, Tanaka Y, Ohno S, Endo M, Okumura N, Takahashi T, Matsuhashi N. Optimal surgical approaches for esophageal epiphrenic diverticulum: literature review and our experience. Clinical Journal of Gastroenterology 16(3):317-324, 2023
  20. Tsuchiya H, Yasufuku I, Fukada M, Higashi T, Asai R, Sato Y, Tajima JY, Kiyama S, Tanaka Y, Okumura N, Murase K, Takahashi T, Matsuhashi N. Postoperative reflux esophagitis in laparoscopic distal gastrectomy with Billroth-I reconstruction for gastric cancer: Nutritional effect and preoperative risk factors. Asian Journal of Endoscopic Surgery, 2023
  21. Futamura M, Nakayama T, Yoshinami T, Oshiro C, Ishihara M, Morita M, Watanabe A, Tanigichi A, Tsukabe M, Shimoda M, Nitta K, Chihara Y, Yasojima H, Ouchi Y, Tokumaru Y, Masuda N. Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316). Breast Cancer, 2023
  22. Nagahashi M, Ling Y, Toshikawa C, Hayashida T, Kitagawa Y, Futamura M, Kuwayama T, Nakamura S, Yamauchi H, Yamauchi T, Kaneko K, Kanbayashi C, Sato N, Tsuchida J, Moro K, Nakajima M, Shimada Y, Ichikawa H, Lyle S, Miyoshi Y, Takabe K, Okuda S, Wakai T. Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients. Breast Cancer 30(4):584-595, 2023
  23. Chikaishi W, Higashi T, Hayashi H, Hanamatsu Y, Kito Y, Futamura M, Matsuhashi N, Saigo C, Takeuchi T. Potential activity of adiponectin-expressing regulatory T cells against triple-negative breast cancer cells through the cell-in-cell phenomenon. Thoracic Cancer 14(20):1941-1945, 2023
  24. Sato Y, Futamura M, Tanaka Y, Tsuchiya H, Fukada M, Higashi T, Yasufuku I, Asai R, Tajima JY, Kiyama S, Hatakeyama H, Morishita M, Hirotsu T, Luccio Ed, Ishihara T, Matsuhashi N, Yoshida K. Clinical Possibility of Caenorhabditis elegans as a Novel Evaluation Tool for Esophageal Cancer Patients Receiving Chemotherapy: A Prospective Study. Cancers 15(15):3870, 2023
  25. Kobayashi S, Bando H, Taketomi A, Takamoto T, Shiozaki E, Shiozawa M, Hara H, Yamazaki K, Komori K, Matsuhashi N, Kato T, Kagawa Y, Yokota M, Oki E, Komine K, Takahashi S, Wakabayashi M, Yoshino T. NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases. BMC Cancer 23(1):779, 2023
  26. Koizumi T, Sugishita Y, Suzuki-Takahashi Y, Nara K, Miyagawa T, Nakajima M, Sugimoto K, Futamura M, Furui T, Takai Y, Matsumoto H, Yamauchi H, Ohno S, Kataoka A, Kawai K, Fukuma E, Nogi H, Tsugawa K, Suzuki N. Oncofertility-related psycho-educational therapy for young adult patients with breast cancer and their partners: randomized controlled trial. Cancer 129(16):2568-2580, 2023
  27. Iihara H, Shimokawa M, Bando H, Niwa Y, Mizuno Y, Kawagichi Y, Kitahora M, Murakami A, Kawai M, Ishida K, Takeuchi M, Ishihara K, Iyoda T, Nakada T, Ogiso A, Kojima Y, Kumagai F, Sawa A, Mori R, Higuchi K, Furuta T, Kamei Y, Tsuchiya M, Terasaki A, Yamamoto S, Kitazawa M, Okazaki M, Suzuki A, Futamura M. Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study. Journal of Cancer 14(14):2644-2654, 2023
  28. Ohno S, Tanaka Y, Sato Y, Endo M, Asai R, Fukada M, Yasufuku I, Okumura N, Takahashi T, Matsuhashi N. A case of advanced hypopharyngeal cervical esophageal cancer treated by curative resection with management of tracheoesophageal fistula. Clinical Journal of Gastroenterology 16(4):508-514, 2023
  29. Chikaishi W, Higashi T, Hayashi H, Hanamatsu Y, Futamura M, Matsuhashi N, Saigo C, Takeuchi T. Adiponectin-expressing Treg-containing T cell fraction inhibits tumor growth in orthotopically implanted triple-negative breast cancer. Thoracic Cancer 1-5, 2023
  30. Iinuma R, Kato H, Yamada T, Sato Y, Tanaka Y, Kato H, Kuroki M, Shibata H, Kohyama K, Ohashi T, Ogawa T. Usefulness of intraoperative monitoring for mesenteric lymph node metastasis in transplanted free jejunum. Auris Nasus Larynx 50(5):827-830, 2023
  31. Kuroki M, Iinuma R, Okuda H, Terazawa K, Shibata H, Mori K, Ohashi T, Makiyama A, Futamura M, Miyazaki T, Horikawa Y, Ogawa T. Comprehensive Genome profile testing in head and neck cancer. Auris Nasus Larynx 50(6):952-959, 2023

邦文論文

  1. 藤林勢世、深田真宏、村瀬勝俊、東敏弥、松橋延壽、高橋孝夫 "高度栄養障害と血液凝固異常をきたした肝血管腫（長径23cm）の1例. 日本臨床外科学会雑誌 83(11):1993-2000, 2022"
  2. 久野真史、横井亮磨、田島ジェシー雄、木山茂、高橋孝夫、松橋延壽 "同時性臍転移を契機に発見された虫垂腹膜偽粘液腫の1例. 日本臨床外科学会雑誌 84(5):764-768, 2023"

著書

  1. 二村学:あけぼの岐阜オンライン「ピンクリボン講演会2022」（2022年9月25日開催）1-12, 2022 乳がん患者さんへのメッセージ 再確認！今の時代だからこそ、知っておきたい留意事項． 2022
  2. 二村学:乳癌診療 state of the art 科学に基づく最新診療 医歯薬出版株式会社、571-574、2022 第25章 他の標的薬・抗がん薬・DDS 4.ナノ粒子結合抗がん薬―特にアブラキサンを中心に、広がる臨床応用の可能性―． 2022
  3. 高橋孝夫:株式会社医学と看護社、1-139、2022年10月20日 第1版第1刷発行、2022 大腸癌術後補助化学療法の適切な選択 ガイドラインやエビデンスに基づいて． 2022
  4. 二村学:AKEBONO NEWS 3:1-24, 2023 あけぼの会全国大会特集号． 2023
  5. 田中善宏:成分栄養剤のこれまでとこれから－エビデンスからの期待－ 株式会社先端医学社 117-122、2023 Part4 がん支持療法における成分栄養剤のこれまでとこれから 3.食道がんの化学療法における成分栄養剤の実際． 2023
  6. 松橋延壽:解剖生理からみちびく消化器ケアQ&A108 消化器ナーシング 2023 春季増刊、株式会社メディカ出版、240-249, 2023 6章 小腸・大腸の解剖生理・疾患・検査・治療・ケア Q17～Q21． 2023
  7. 二村学:乳腺外科の要点と盲点 第3版、株式会社 文光堂、113-115, 2023 Ⅳ.手術方法決定 5.腋窩リンパ節郭清． 2023

メディア

  1. 二村学:岐阜新聞,女性のヘルスアッププロジェクト－Vol.01 まずは、わたしが持続可能に！．,4面, 2022.9.6
  2. 二村学:中日新聞,「乳がん」検診とセルフチェックで生命を守る 乳房に関心を持ち「ブレスト・アウェアネス」を心がける. 2022.9.24
  3. 二村学:岐阜新聞,乳がん 定期検診を 来月ピンクリボン月間 岐阜市で啓発活動．,12面, 2022.9.26
  4. 二村学:"岐阜新聞,10月は「乳がん月間」検診・受診で早期発見・早期治療. 2022.10.1"
  5. 二村学:"岐阜新聞,10月は「乳がん月間」検診・受診で早期発見・早期治療. 2022.10.8"
  6. 二村学:"岐阜ラジオ,ぎふピンクリボン〜まずは、わたしが持続可能に！ 2022.10.22"
  7. 二村学:"医療と介護ガイドブック,ぎふピンクリボン ドクターズインタビュー 乳がんは治るがん。検診の受診で早期発見・治療を．,10-11ページ 2022.11.1"
  8. 二村学:中日新聞,紙上診察室 乳がん検診「局所的非対称性陰影」慌てず精密検査を．,14面, 2022.12.27
  9. 二村学:ぎふピンクリボン実行委員会,ぎふピンクリボン実行委員会 2022年度活動報告,1-10ページ, 2023.3
  10. 松橋延壽:"岐阜新聞,特集 岐阜の医療を考える もっと知ろうがんのこと「3月は大腸がん啓発月間」新たな治療が続々 大腸がんは治る、消える時代へ．,10面 2023.3.30"
  11. 松橋延壽、田中善宏、佐藤悠太:"岐阜新聞,特集 岐阜の医療を考える もっと知ろうがんのこと「4月は食道がん啓発月間」食道がん治療 研究が進み着実に前進. 2023.4.23"
  12. 松橋延壽:"東海医事新報社,講座クローズアップ 岐阜大学大学院医学系研究科外科学講座 消化器外科・小児外科学分野「医は仁術」を信条に、先進的な研究・教育を推進．,34面 2023.6.20"
  13. 二村学:"JBCRGニュース,新役員のご紹介．,一般社団法人JBCRG 1-11ページ 2023.6.26"
  14. 二村学:"岐阜県医師会,乳がんって、人事と思っていませんか？．,岐阜県医師会ラジオホームドクター 2023.7.13"
  15. 二村学:"岐阜県医師会,こんなに進んだ乳がん治療．,岐阜県医師会ラジオホームドクター 2023.7.14"
  16. 松橋延壽:産経新聞,大腸がんを考える 岐阜大学医学部附属病院 消化器外科．,18面, 2023.7.17
  17. 二村学:"岐阜新聞,まずは、わたしが持続可能に. 2023.8.25"